About Molecular NeuroImaging
Molecular NeuroImaging is a company based in New Haven (United States) founded in 2000 was acquired by Invicro in February 2016. The company has 161 employees as of December 31, 2017. Molecular NeuroImaging offers products and services including Imaging Core Lab, Clinical Adjudication, eClinical, and Preclinical Imaging. Molecular NeuroImaging operates in a competitive market with competitors including Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
- Headquarter New Haven, United States
- Employees 161 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Molecular Neuroimaging Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular NeuroImaging
Molecular NeuroImaging offers a comprehensive portfolio of products and services, including Imaging Core Lab, Clinical Adjudication, eClinical, and Preclinical Imaging.
Provides high-quality imaging data for global clinical trials
Independent review of trial event assessments for accuracy
Offers randomization and supply management solutions
Supports study designs in pharmaceutical R&D processes
Funding Insights of Molecular NeuroImaging
Investors in Molecular NeuroImaging
Molecular NeuroImaging has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, Invicro and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Scientific and technical information is managed and disseminated by OSTI.GOV.
|
Locked | Locked | Locked | |
|
Provide contract research imaging services and software
|
Locked | Locked | Locked |
Investor details for Molecular NeuroImaging
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular NeuroImaging
Investment portfolio details for Molecular NeuroImaging
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecular NeuroImaging
Detailed financials for Molecular NeuroImaging
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Neuroimaging Comparisons
Peer comparison for Molecular NeuroImaging
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular NeuroImaging
Molecular NeuroImaging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
Electron microscopy services and microanalysis instruments are provided.
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
Detailed competitors of Molecular NeuroImaging
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Neuroimaging
Complete news archive for Molecular NeuroImaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular NeuroImaging
Molecular NeuroImaging was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Molecular NeuroImaging is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
As of Dec 31, 2017, the latest employee count at Molecular NeuroImaging is 161.
Founded in 2000 and based in New Haven, United States, Molecular NeuroImaging operates in the neuroimaging sector, focusing on PET and SPECT biomarkers for drug development and clinical research in neurodegenerative and neuropsychiatric disorders. Services include radioligand development, manufacturing, imaging study design for Phases 1-4 trials, multi-site coordination, and quantitative image analysis. Expertise covers 22 CNS targets and conditions such as Alzheimers disease, Parkinsons disease, and multiple sclerosis.
Molecular NeuroImaging's top competitors include Thermo Fisher Scientific, Biocare Medical and Merck.
Molecular NeuroImaging offers Imaging Core Lab, Clinical Adjudication, eClinical, and Preclinical Imaging.